MultiPark (Multidisciplinary research focused on Parkinson´s disease) is a strategic research area (SRA) supported by the Swedish Government. Through a comprehensive scientific programme we aim at unraveling basic disease mechanisms, improving diagnostics precision, and developing efficient methods of treatment and carefor people affected by neurodegenerative diseases. Building on a tradition of excellence in dopamine research at Lund University, the MultiPark programme was originally focused on Parkinson’s disease. Our network has gradually expanded to incorporate excellent research groups studying Alzheimer´s and Huntington´s disease, or neurodegeneration secondary to brain trauma and stroke.